← Back to patent-cliff list
泼尼松龙/盐酸四氢唑啉
Tier C — Watch / tradePrednisolone/Tetrahydrozoline Hydrochloride
-
Originator
2008
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRA1、GR
Brand：Cor-Tyzine
Indications (approved)：鼻塞
Regional status
US
-
EU
-
China
-
Japan
批准上市
2008-03-07
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Prednisolone/Tetrahydrozoline Hydrochloride?
Approved indications include: 鼻塞.
When does the Prednisolone/Tetrahydrozoline Hydrochloride patent expire?
No public expiry year is available for Prednisolone/Tetrahydrozoline Hydrochloride yet; this page updates once verified.
How do I get a quote for Prednisolone/Tetrahydrozoline Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24